Novartis Investigative Site

New Westminster, British Columbia V3L 3W4

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Heart Failure With Reduced Ejection Fraction, Leukaemia, Lymphocytic, Chronic

Studies at this site

• Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early